Revolution Medicines

General Information
Business:

 

We are a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, high-value frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. We define frontier targets as proteins that play an important role in cancer and for which there is either: (1) no approved drug that directly inhibits it, or (2) one or more approved drugs that directly inhibit it but through a mechanism of action that may not enable suppression of the full range of its biologic contributions to cancer.

Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Employees: 90
Founded: 2014
Contact Information
Address 700 Saginaw Drive, Redwood City, CA 94063, US
Phone Number (650) 481-6801
Web Address http://www.revmed.com
View Prospectus: Revolution Medicines
Financial Information
Market Cap $967.3mil
Revenues $48.3 mil (last 12 months)
Net Income $-56.9 mil (last 12 months)
IPO Profile
Symbol RVMD
Exchange NASDAQ
Shares (millions): 14.0
Price range $17.00 - $17.00
Est. $ Volume $238.0 mil
Manager / Joint Managers J.P. Morgan/ Cowen/ SVB Leerink/ Guggenheim Securities
CO-Managers -
Expected To Trade: 2/13/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change